OncoCyte Corporation (AMEX: OCX) flaunted slowness of -0.33% at $5.98, as the Stock market unbolted on 2/8/2021,before settling in for the price of $6.00 at the close. Taking a more long-term approach, OCX posted a 52-week range of $1.15-$6.30.
Meanwhile, its Annual Earning per share during the time was -17.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -5.00%. This publicly-traded company’s shares outstanding now amounts to $67.25 million, simultaneously with a float of $33.78 million. The organization now has a market capitalization sitting at $416.33 million. At the time of writing, stock’s 50-day Moving Average stood at $3.23, while the 200-day Moving Average is $2.21.
OncoCyte Corporation (OCX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the OncoCyte Corporation industry. OncoCyte Corporation’s current insider ownership accounts for 0.80%, in contrast to 40.00% institutional ownership. According to the most recent insider trade that took place on Jan 20, this organization’s 10% Owner bought 1,460,280 shares at the rate of 3.42, making the entire transaction reach 4,999,999 in total value, affecting insider ownership by 16,176,484. Preceding that transaction, on Dec 23, Company’s Director sold 900 for 2.55, making the whole transaction’s value amount to 2,295. This particular insider is now the holder of 318,840 in total.
OncoCyte Corporation (OCX) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.1 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.09) by -$0.01. This company achieved a return on equity of -130.91. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
OncoCyte Corporation’s EPS decrease for this current 12-month fiscal period is -5.00% and is forecasted to reach -0.36 in the upcoming year.
OncoCyte Corporation (AMEX: OCX) Trading Performance Indicators
Let’s observe the current performance indicators for OncoCyte Corporation (OCX). It’s Quick Ratio in the last reported quarter now stands at 1.30. The Stock has managed to achieve an average true range (ATR) of 0.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 594.75.
In the same vein, OCX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.51, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.36 at the market close of one year from today.
Technical Analysis of OncoCyte Corporation (OCX)
Now, what If we examine the latest scores posted by [OncoCyte Corporation, OCX]. During the last 5-days, its volume was better the volume of 1.8 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 74.05% While, its Average True Range was 0.62.
Raw Stochastic average of OncoCyte Corporation (OCX) in the period of the previous 100 days is set at 93.73%, which indicates a major rise in contrast to 88.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 165.31% that was higher than 101.33% volatility it exhibited in the past 100-days period.